New York City Mayor Bill de Blasio is cranking up the heat in its fight against climate change and pollution by suing major oil companies. The lawsuit names BP, Chevron, ConocoPhillips, Exxon Mobil, and Royal Dutch Shell as defendants for causing serious harm to the environment despite being aware of the effects of its products. What’s more, the city is also divesting away from fossil fuel, using its Pension Funds to pressure these oil giants.
The federal lawsuit that Mayor de Blasio’s office just filed is basically seeking reparations from the companies in the wake of the devastation that the city suffered due to several super storms, The New York Post reports. The lawsuit argues that the responsibility for the escalating natural disasters due to climate change falls on these oil companies, which have reaped the benefits of polluting the atmosphere.
“The city seeks to shift the costs of protecting the city from climate change impacts back onto the companies that have done nearly all they could to create this existential threat,” the lawsuit reads.
Naturally, the move prompted swift condemnation from the fossil fuel industry. Chevron spokesman Braden Reddall spoke to ABC News and said that suing oil companies will not help efforts to combat climate change.
“Reducing greenhouse gas emissions is a global issue and requires global participation and actions. Lawsuits of this kind — filed by trial attorneys against an industry that provides products we all rely upon to power the economy and enable our domestic life — simply do not do that,” Reddall said.
Aside from the lawsuit, Mayor de Blasio and Comptroller Scott Stringer have also announced that they’ll be taking their $5 billion investment in fossil fuel, courtesy of NYC’s Pension Funds in a divestment that might be more effective than legal action. This is in line with many divestment efforts by many states and provinces all across the world, which is putting the fossil fuel industry in a tight spot.


China vs. NASA: The New Moon Race and What's at Stake by 2030
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Tabletop particle accelerator could transform medicine and materials science
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



